BioNTech
ISIN US09075V1026
|WKN A2PSR2
Overview
Description
BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.
Healthcare Biopharmaceuticals Non-System-Specific Biopharmaceuticals Germany
Chart
Financials
Key metrics
| Market capitalisation, EUR | 19,547.52 m |
| EPS, EUR | 3.85 |
| P/B ratio | 0.92 |
| P/E ratio | 20.74 |
| Dividend yield | 0.00% |
Income statement (2023)
| Revenue, EUR | 3,819.05 m |
| Net income, EUR | 930.31 m |
| Profit margin | 24.36% |
What ETF is BioNTech in?
There are 30 ETFs which contain BioNTech. All of these ETFs are listed in the table below. The ETF with the largest weighting of BioNTech is the VanEck Genomics and Healthcare Innovators UCITS ETF A.
| ETF | Weight | Investment focus | Holdings | TER | Fund size (in m EUR) | Return 1Y | WKN | ISIN |
|---|---|---|---|---|---|---|---|---|
| Amundi Prime Global UCITS ETF DR (D) | 0.02% | Equity World | 1,475 | 0.05% | 688 | +23.49% | A2PBLJ | LU1931974692 |
| BNP Paribas Easy ECPI Global ESG Med Tech UCITS ETF USD | 1.73% | Equity World Health Care Social/Environmental | 50 | 0.30% | 1 | -1.96% | A3D4V3 | LU2533811084 |
| Amundi S&P Global Health Care ESG UCITS ETF DR EUR (D) | 0.12% | Equity World Health Care Social/Environmental | 113 | 0.18% | 10 | +8.21% | A3DSTD | IE000JKS50V3 |
| WisdomTree BioRevolution UCITS ETF USD Acc | 0.77% | Equity World Health Care Social/Environmental Biotech | 88 | 0.45% | 3 | -7.81% | A3CY21 | IE000O8KMPM1 |
| Amundi F.A.Z. 100 UCITS ETF Dist | 1.30% | Equity Germany | 96 | 0.15% | 88 | +7.04% | ETF196 | LU2611732129 |
| Xtrackers EMU Net Zero Pathway Paris Aligned UCITS ETF 1C | 0.44% | Equity Europe Social/Environmental Climate Change | 157 | 0.15% | 17 | +10.86% | DBX0RW | IE000Y6L6LE6 |
| BNP Paribas Easy ECPI Global ESG Med Tech UCITS ETF EUR | 1.73% | Equity World Health Care Social/Environmental | 50 | 0.30% | 14 | -2.45% | A3C9H4 | LU2365457410 |
| L&G Global Equity UCITS ETF | 0.01% | Equity World Social/Environmental | 1,237 | 0.10% | 106 | +23.83% | A2N4PQ | IE00BFXR5S54 |
| Xtrackers S&P Europe ex UK UCITS ETF | 0.10% | Equity Europe | 345 | 0.09% | 475 | +11.87% | A2JCAG | IE00BGV5VM45 |
| Amundi Prime All Country World UCITS ETF DIST (D) | 0.02% | Equity World | 1,109 | 0.07% | 97 | - | ETF150 | IE0009HF1MK9 |
| Invesco S&P World Health Care ESG UCITS ETF Acc | 0.08% | Equity World Health Care Social/Environmental | 90 | 0.18% | - | +8.48% | A3D3BE | IE000L4EH2K5 |
| Amundi Prime Global UCITS ETF DR (C) | 0.02% | Equity World | 1,475 | 0.05% | 307 | +23.51% | A2PWMK | LU2089238203 |
| WisdomTree Megatrends UCITS ETF USD | 0.05% | Equity World Social/Environmental Innovation | 582 | 0.50% | 9 | - | A3EYCN | IE0000902GT6 |
| Xtrackers World Biodiversity Focus SRI UCITS ETF 1C | 0.02% | Equity World Social/Environmental | 653 | 0.30% | 10 | - | DBX0UK | IE000E0V65D8 |
| VanEck Genomics and Healthcare Innovators UCITS ETF A | 3.56% | Equity World Health Care Social/Environmental Innovation | 52 | 0.35% | 6 | -11.43% | A3DSGJ | IE000B9PQW54 |
| Xtrackers World Net Zero Pathway Paris Aligned UCITS ETF 1C | 0.04% | Equity World Social/Environmental Climate Change | 1,106 | 0.19% | 25 | +20.70% | DBX0RU | IE000UZCJS58 |
| Amundi US Tech 100 Equal Weight UCITS ETF DR USD D | 0.85% | Equity United States Technology Equal Weighted | 100 | 0.07% | 528 | +26.94% | ETF026 | IE000Y9MG996 |
| Global X Genomics & Biotechnology UCITS ETF | 3.11% | Equity World Health Care Biotech | 41 | 0.50% | 6 | -17.62% | A2QRCP | IE00BM8R0N95 |
| Invesco Nasdaq Next Generation 100 UCITS ETF Acc | 0.58% | Equity United States Technology | 104 | 0.25% | 41 | +14.69% | A2QPVX | IE00BMD8KP97 |
| Amundi Prime Europe UCITS ETF DR (D) | 0.08% | Equity Europe | 445 | 0.05% | 55 | +11.07% | A2PBLF | LU1931974262 |
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 0.88% | Equity United States Health Care Biotech | 222 | 0.35% | 32 | +0.41% | A2JDYM | IE00BDZVHG35 |
| Amundi S&P Global Health Care ESG UCITS ETF DR EUR (A) | 0.12% | Equity World Health Care Social/Environmental | 113 | 0.18% | 234 | +8.19% | A3DSTC | IE0006FM6MI8 |
| iShares Nasdaq US Biotechnology UCITS ETF | 0.88% | Equity United States Health Care Biotech | 222 | 0.35% | 416 | +0.18% | A2DWAW | IE00BYXG2H39 |
| Amundi S&P Eurozone PAB Net Zero Ambition UCITS ETF Acc | 0.21% | Equity Europe Social/Environmental Climate Change | 134 | 0.20% | 1,791 | +14.77% | LYX05H | LU2195226068 |
| L&G Europe ex UK Equity UCITS ETF | 0.10% | Equity Europe Social/Environmental | 347 | 0.10% | 264 | +11.68% | A2N4PS | IE00BFXR5V83 |
| Invesco Dow Jones Islamic Global Developed Markets UCITS ETF Acc | 0.02% | Equity World Islamic Investing | 1,778 | 0.40% | - | +25.72% | A3C6Z0 | IE000UOXRAM8 |
| Amundi Prime Eurozone UCITS ETF DR (C) | 0.17% | Equity Europe | 214 | 0.05% | 57 | +13.97% | A2PWMJ | LU2089238112 |
| Amundi Prime Eurozone UCITS ETF DR (D) | 0.17% | Equity Europe | 214 | 0.05% | 44 | +13.97% | A2PBLH | LU1931974429 |
| Xtrackers Europe Net Zero Pathway Paris Aligned UCITS ETF 1C | 0.18% | Equity Europe Social/Environmental Climate Change | 329 | 0.15% | 5 | +9.10% | DBX0SQ | IE0001JH5CB4 |
| Amundi Prime Europe UCITS ETF DR (C) | 0.08% | Equity Europe | 445 | 0.05% | 29 | +11.38% | A2PWMH | LU2089238039 |
Performance
Returns overview
| YTD | -16.16% |
| 1 month | -5.54% |
| 3 months | -9.10% |
| 6 months | -11.66% |
| 1 year | -24.87% |
| 3 years | -44.17% |
| 5 years | - |
| Since inception (MAX) | +517.36% |
| 2023 | -35.01% |
| 2022 | -29.26% |
| 2021 | +174.30% |
| 2020 | +149.41% |
Monthly returns in a heat map
Risk
Risk metrics in this section:
- Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
- Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
- Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.
Risk overview
| Volatility 1 year | 34.83% |
| Volatility 3 years | 58.40% |
| Volatility 5 years | - |
| Return per risk 1 year | -0.71 |
| Return per risk 3 years | -0.30 |
| Return per risk 5 years | - |
| Maximum drawdown 1 year | -29.63% |
| Maximum drawdown 3 years | -78.45% |
| Maximum drawdown 5 years | - |
| Maximum drawdown since inception | -78.45% |
Rolling 1 year volatility
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.